MR-Linac radiotherapy for prostate cancer that returned after earlier radiation
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests if a special MRI-guided radiotherapy machine (MR-Linac) can safely treat prostate cancer that has come back after previous radiation therapy. It may help men who have limited options and want to avoid more invasive treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older
- You had prostate cancer that was treated with external beam radiation before and it came back (confirmed by biopsy)
- Your testosterone level is at least 50 ng/dL (you may have used hormone therapy in the past if your testosterone is now above that level)
- You are in fairly good health (able to care for yourself and do daily activities)
- You have a prostate smaller than 90 cc and your MRI shows a visible tumor
- You have not had prostate brachytherapy, cryotherapy, or HIFU before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.
This trial tests a type of radiation that adjusts to changes in your prostate during treatment. It aims to improve accuracy and reduce side effects for men with intermediate- or high-risk prostate cancer.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial tests a precise radiation treatment for prostate cancer that has come back in the prostate bed after surgery, using a special MRI-guided approach to target the spot while protecting nearby organs, which may help delay or stop further cancer growth.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
Hear when a new Intraprostatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.